Anthropic, the artificial intelligence company backed by Amazon.com Inc., has established a biology laboratory to support its expanding drug discovery program, according to a report from Reuters.
The new facility is reportedly being used to test the company's AI models on biological data. This move suggests Anthropic is moving beyond general-purpose AI research into specialized applications within the life sciences sector.
The report notes that the lab is part of Anthropic's broader efforts to ramp up its capabilities in AI for drug development. The company is leveraging its large language models to analyze complex biological information.
Anthropic was founded in 2021 and is known for developing AI systems focused on safety and reliability. The company has received significant investment from Amazon, which holds a minority stake in the firm.
